{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:37:11Z","timestamp":1762508231302,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T00:00:00Z","timestamp":1598832000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jctejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical &amp; Translational Endocrinology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jcte.2020.100235","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T23:48:22Z","timestamp":1599004102000},"page":"100235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Impact of first-line treatment choice on long-term outcomes of hyperthyroid Graves\u2019 disease patients with thyrotoxic periodic paralysis"],"prefix":"10.1016","volume":"21","author":[{"given":"Krittadhee","family":"Karndumri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yotsapon","family":"Thewjitcharoen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waralee","family":"Chatchomchuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sriurai","family":"Porramatikul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sirinate","family":"Krittiyawong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekgaluck","family":"Wanothayaroj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siriwan","family":"Butadej","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soontaree","family":"Nakasatien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajata","family":"Rajatanavin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thep","family":"Himathongkam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcte.2020.100235_b0005","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1210\/endo-15-6-541","article-title":"A syndrome resembling familial periodic paralysis occurring in the course of exophthalmic goiter","volume":"15","author":"Dunlap","year":"1931","journal-title":"Endocrinology"},{"key":"10.1016\/j.jcte.2020.100235_b0010","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1001\/archinte.1989.00390110139031","article-title":"Thyrotoxic periodic paralysis. Report of 10 cases and review of electromyographic findings","volume":"149","author":"Kelley","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jcte.2020.100235_b0015","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00005792-199205000-00001","article-title":"Thyrotoxic periodic paralysis in the United States: report of 7 cases and review of the literature","volume":"71","author":"Ober","year":"1992","journal-title":"Medicine"},{"key":"10.1016\/j.jcte.2020.100235_b0020","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archinte.159.6.601","article-title":"Clinical and metabolic features of thyrotoxic periodic paralysis in 24 episodes","volume":"159","author":"Manoukian","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jcte.2020.100235_b0025","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1507\/endocrj1954.39.315","article-title":"Comparison of the incidence of association of periodic paralysis and hyperthyroidism in Japan in 1957 and 1991","volume":"39","author":"Shizume","year":"1992","journal-title":"Endocrinol Jpn"},{"key":"10.1016\/j.jcte.2020.100235_b0030","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/qjmed\/89.6.463","article-title":"Thyrotoxic periodic paralysis in a Chinese population","volume":"89","author":"Ko","year":"1996","journal-title":"QJM"},{"key":"10.1016\/j.jcte.2020.100235_b0035","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1530\/EJE-09-0553","article-title":"Therapeutic analysis in Chinese patients with thyrotoxic periodic paralysis over 6 years","volume":"161","author":"Shiang","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jcte.2020.100235_b0040","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/RLU.0b013e3182817c31","article-title":"Thyrotoxic periodic paralysis in Chinese patients: milder thyrotoxicosis yet lower dose of (131) I should be avoided","volume":"38","author":"Long","year":"2013","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.jcte.2020.100235_b0045","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.jcte.2020.100235_b0050","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0025-6196(11)62965-0","article-title":"Thyrotoxic periodic paralysis","volume":"80","author":"Lin","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jcte.2020.100235_b0055","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1089\/thy.2007.0315","article-title":"Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy","volume":"18","author":"Bartalena","year":"2008","journal-title":"Thyroid"},{"key":"10.1016\/j.jcte.2020.100235_b0060","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1468-1331.2008.02132.x","article-title":"Hypokalemic thyrotoxic periodic paralysis: clinical characteristics and predictors of recurrent paralytic attacks","volume":"15","author":"Hsieh","year":"2008","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jcte.2020.100235_b0065","unstructured":"Yeo PPB, Lee KO, Cheah JS. Thyrotoxic periodic paralysis: A study of 51 patients. In: Proceedings of the Second Congress of the Association of Southeast Asian Nations (ASEAN) Federation of Endocrine Societies, 30 Nov-3 Dec, Bangkok, Thailand, 1983."},{"key":"10.1016\/j.jcte.2020.100235_b0070","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1210\/jc.2006-0356","article-title":"Clinical review: thyrotoxic periodic paralysis: a diagnostic challenge","volume":"91","author":"Kung","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2020.100235_b0075","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/649502","article-title":"Thyrotoxic periodic paralysis: clinical challenges","volume":"2014","author":"Vijayakumar","year":"2014","journal-title":"J Thyroid Res"},{"key":"10.1016\/j.jcte.2020.100235_b0080","first-page":"274","article-title":"Thyrotoxic periodic paralysis: clinical and molecular aspects","volume":"43","author":"Falhammar","year":"2013","journal-title":"Endocrine"},{"key":"10.1016\/j.jcte.2020.100235_b0085","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jemermed.2018.04.063","article-title":"Changing management guidelines in thyrotoxic hypokalemic periodic paralysis","volume":"55","author":"Correia","year":"2018","journal-title":"J Emerg Med"},{"key":"10.1016\/j.jcte.2020.100235_b0090","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1210\/jc.2015-3564","article-title":"Periodic paralysis as a new phenotype of resistance to thyroid hormone syndrome in a Chinese male adult","volume":"101","author":"Ma","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2020.100235_b0095","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1530\/EJE-13-0381","article-title":"A 10-year analysis of thyrotoxic periodic paralysis in 135 patients: focus on symptomatology and precipitants","volume":"169","author":"Chang","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jcte.2020.100235_b0100","first-page":"289","article-title":"Endemic primary distal renal tubular acidosis in Thailand","volume":"74","author":"Nilwarangkur","year":"1990","journal-title":"Q J Med"},{"key":"10.1016\/j.jcte.2020.100235_b0105","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1093\/ndt\/gfh328","article-title":"Hypokalaemia and paralysis in the Thai population","volume":"19","author":"Phakdeekitcharoen","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jcte.2020.100235_b0110","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nrendo.2011.58","article-title":"Novel etiopathophysiological aspects of thyrotoxic periodic paralysis","volume":"7","author":"Maciel","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.jcte.2020.100235_b0115","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s12020-010-9396-3","article-title":"Effects of sex steroid hormones, thyroid hormone levels, and insulin regulation on thyrotoxic periodic paralysis in Chinese men","volume":"38","author":"Li","year":"2010","journal-title":"Endocrine"},{"key":"10.1016\/j.jcte.2020.100235_b0120","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/0140-6736(91)91710-C","article-title":"Hyperinsulinemia in thyrotoxic hypokalemic periodic paralysis","volume":"337","author":"Lee","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.jcte.2020.100235_b0125","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1365-2265.2008.03395.x","article-title":"Insulin resistance in subjects with a history of thyrotoxic periodic paralysis (TPP)","volume":"70","author":"Soonthornpun","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jcte.2020.100235_b0130","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1681\/ASN.2012010046","article-title":"Mechanism of thyrotoxic periodic paralysis","volume":"23","author":"Lin","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jcte.2020.100235_b0135","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cell.2009.12.024","article-title":"Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis","volume":"140","author":"Ryan","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jcte.2020.100235_b0140","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/jhg.2012.20","article-title":"A genome-wide association study identifies novel susceptibility genetic variation for thyrotoxic hypokalemic periodic paralysis","volume":"57","author":"Jongjaroenprasert","year":"2012","journal-title":"J Hum Genet"},{"key":"10.1016\/j.jcte.2020.100235_b0145","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12883-015-0290-8","article-title":"The clinical and genetic features in a cohort of mainland Chinese patients with thyrotoxic periodic paralysis","volume":"15","author":"Li","year":"2015","journal-title":"BMC Neurol"},{"key":"10.1016\/j.jcte.2020.100235_b0150","doi-asserted-by":"crossref","unstructured":"Rita Yuk-Kwan Chang, Brian Hung-Hin Lang, Ai Chen Chan, Kai Pun Wong. Evaluating the efficacy of primary treatment for Graves' disease complicated by thyrotoxic periodic paralysis. Int J Endocrinol. 2014;2014:949068.","DOI":"10.1155\/2014\/949068"},{"key":"10.1016\/j.jcte.2020.100235_b0155","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8175712","article-title":"Diagnosis and management of Graves\u2019 disease in Thailand: a survey of current practice","author":"Sriphrapradang","year":"2020","journal-title":"J Thyroid Res"},{"key":"10.1016\/j.jcte.2020.100235_b0160","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.amjsurg.2011.01.029","article-title":"Changing trend in surgical indication and management for Graves' disease","volume":"203","author":"Yip","year":"2012","journal-title":"Am J Surg"}],"container-title":["Journal of Clinical &amp; Translational Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214623720300880?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214623720300880?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:56:18Z","timestamp":1762005378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214623720300880"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":32,"alternative-id":["S2214623720300880"],"URL":"https:\/\/doi.org\/10.1016\/j.jcte.2020.100235","relation":{},"ISSN":["2214-6237"],"issn-type":[{"type":"print","value":"2214-6237"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of first-line treatment choice on long-term outcomes of hyperthyroid Graves\u2019 disease patients with thyrotoxic periodic paralysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical & Translational Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcte.2020.100235","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100235"}}